Category Matches
- 0.1 mg
- 0.5 mg
- 10 g
- 10 mg
- 10 ml
- 10 µg
- 100 g
- 100 mg
- 100 mh
- 100 ml
- 100 Tests
- 100 µg
- 100-200 Tests
- 1000 g
- 100g
- 11β-HSD Inhibitor
- 125 Tests
- 2 Plates
- 2-Deoxy-D-Glucose
- 2-deoxy-D-glucose
- 20 g
- 20 mg
- 20 Tests
- 200 Tests
- 200 µg
- 24 Tests
- 25 Tests
- 25-250 Tests
- 25-50 Tests
- 250 g
- 250 mg
- 250 ml
- 250 Tests
- 250 µg
- 250mg
- 30S
- 4 Plates
- 400 Tests
- 5 Plates
- 5 x 100 µg
- 5 x 50 µg
- 5-a-reductase Inhibitors
- 5-HT1 Receptors - Analgesics
- 5-HT1 Receptors - Antidepressant
- 5-HT1 Receptors - Antipsychotic
- 5-HT1 Receptors - Anxiolytic
- 5-HT1 Receptors - Cognition Enhancing
- 5-HT1 Receptors - Hypnotics
- 5-HT1 Receptors - Sedatives
- 5-HT2 Receptors - Analgesics
- 5-HT2 Receptors - Antidepressant
- 5-HT2 Receptors - Antipsychotic
- 5-HT2 Receptors - Anxiolytic
- 5-HT2 Receptors - Cognition Enhancing
- 5-HT2 Receptors - Hypnotics
- 5-HT2 Receptors - Neurodegenerative Diseases
- 5-HT2 Receptors - Sedatives
- 5-HT3 Receptors - Analgesics
- 5-HT3 Receptors - Antidepressant
- 5-HT3 Receptors - Antipsychotic
- 5-HT3 Receptors - Anxiolytic
- 5-HT3 Receptors - Cognition Enhancing
- 5-HT3 Receptors - Hypnotics
- 5-HT3 Receptors - Sedatives
- 5-HT5 Receptors - Analgesics
- 5-HT5 Receptors - Antidepressant
- 5-HT5 Receptors - Antipsychotic
- 5-HT5 Receptors - Anxiolytic
- 5-HT5 Receptors - Cognition Enhancing
- 5-HT5 Receptors - Neurodegenerative Diseases
- 5-HT5 Receptors - Sedatives
- 5-HT6 Receptors - Analgesics
- 5-HT6 Receptors - Antidepressant
- 5-HT6 Receptors - Antipsychotic
- 5-HT6 Receptors - Anxiolytic
- 5-HT6 Receptors - Cognition Enhancing
- 5-HT6 Receptors - Neurodegenerative Diseases
- 5-HT6 Receptors - Sedatives
- 5-HT7 Receptors - Analgesics
- 5-HT7 Receptors - Antidepressant
- 5-HT7 Receptors - Antipsychotic
- 5-HT7 Receptors - Anxiolytic
- 5-HT7 Receptors - Cognition Enhancing
- 5-HT7 Receptors - Sedatives
- 5-Lipoxygenase Inhibitors
- 5-α-Reductase Inhibitors
- 50 g
- 50 mg
- 50 ml
- 50 Tests
- 50 U
- 50 µg
- 50-100 Tests
- 500 g
- 500 KU
- 500 mg
- 500 mL
- 500 mt
- 500 Tests
- 500 µg
- 500 µl
- 500µg
- 50S
- 5x50 µg
- 6 Tests
- a-Glucosidase Inhibitors
- ACE Inhibitors
- Acetic Acid Derivatives
- Acetyl-CoA Carboxylase Inhibitor
- AChE - Neurodegenerative Diseases
- ACTH Agonists
- Activin-like Kinase
- Adenosine
- Adenosine Antagonists (Xanthines)
- Adenosine Receptors - Analgesics
- Adenosine Receptors - Antiepileptics and Anticonvulsants
- Adenosine Receptors - Anxiolytic
- Adenosine Receptors - Cognition Enhancing
- Adenosine Receptors - Neurodegenerative Diseases
- Adenosine Receptors - Sedatives
- Adenosine/Adenine
- Adrenal Hormones and Modulators
- Adrenergic Agonists
- Adrenergic Receptors - Analgesics
- Adrenergic Receptors - Anesthetic
- Adrenergic Receptors - Antidepressant
- Adrenergic Receptors - Antiepileptics and Anticonvulsants
- Adrenergic Receptors - Antipsychotic
- Adrenergic Receptors - Anxiolytic
- Adrenergic Receptors - Cognition Enhancing
- Adrenergic Receptors - Hypnotics
- Adrenergic Receptors - Neurodegenerative Diseases
- Adrenergic Receptors - Sedatives
- adu-s100
- adus100
- Aldosterone and ENaC Antagonists (K+ Sparing diuretics)
- Aldosterone Antagonists
- Aldosterone Antagonists - Antihypertensive
- alkaloids
- Alkyl Sulfonates
- ally disulfide
- allylamines
- ALS
- Alzheimer's
- Alzheimer's Disease
- Alzheimer's Disease
- Amino acid Neurotransmitters
- aminocoumarins
- aminoglycosides
- Aminonucleosides
- AMPA - Analgesics
- AMPA - Antipsychotic
- AMPA - Neurodegenerative Diseases
- AMPA - Sedatives
- amphenicols
- Amphibian peptides and Hormones
- AMPK - Neurodegenerative Diseases
- AMPs
- Amylin Agonists
- Amyotrophic Lateral Sclerosis
- anabasine
- Analgesics and Antinociceptives
- anastrozole
- Androgen Receptor Modulators
- Androgen Synthesis Inhibitors
- Androgens
- Anesthetic
- Angiotensin
- Angiotensin II Inhibitors
- Ansamycins
- Anti-arthritics
- Anti-asthma
- Anti-atherosclerotic
- Anti-glucocorticoids
- Anti-metastatic
- Anti-mineralocorticoids
- Anti-mitotics
- Anti-osteoporotics
- Anti-parasitic
- Anti-parasitic
- Anti-pruritics
- Anti-psoriatics
- Anti-resorptives
- anti-tuberculosis
- Anti-ulceratives and Antacids
- Antiandrogens
- Anticholinergics
- Anticoagulants
- Antidepressant
- Antiepileptics and Anticonvulsants
- Antiestrogens
- Antifolates
- Antihistamines
- Antihistamines - Therapies for Respiratory Diseases and Allergy Management
- Antihyperlipidemics
- Antihypertensive
- Antimicrobial - Peptides
- Antimicrobial Peptides - Microbiology
- Antimicrobial Peptides - Natural Products
- Antimicrobial Peptides - Others
- Antimitotics
- Antimitotics
- Antiplatelet Compounds
- Antiprogestogens
- Antipropulsives
- Antipsychotic
- antituberculosis
- antitussive
- Apitolisib
- Appetite Modulators
- arbovirus
- Aromatase Inhibitors - Anticancer
- Aromatase Inhibitors - Immunology
- artemisia
- artesunate
- Arthropod peptides and Hormones
- ASK
- Avermectins
- AZ-5104
- AZ5104
- AZD-1208
- Azoles
- B02
- Bacteriostatics
- BAY1816032
- BAY80-6946
- BChE - Neurodegenerative Diseases
- Beta Blockers - Anti-anginal
- Beta-Adrenergic Agonists
- Beta-Adrenergic Receptor Antagonists
- Biguanides
- Biochemicals
- Bisphosphonates
- BIX01294
- Blog Post
- BMS-754807
- Bone Disease Treatments
- budesonide
- Ca2+ Channel Blockers - Anti-anginal
- Ca2+ Channel Blockers - Antihypertensive
- Ca2+ Channel Blockers - Vasodilatory
- Ca2+ Channels - Analgesics
- Ca2+ Channels - Anesthetic
- Ca2+ Channels - Antidepressant
- Ca2+ Channels - Antiepileptics and Anticonvulsants
- Ca2+ Channels - Antipsychotic
- Ca2+ Channels - Anxiolytic
- Ca2+ Channels - Cognition Enhancing
- Ca2+ Channels - Sedatives
- Ca2+ Ion Channels - Neurodegenerative Diseases
- Ca2+-sensing Receptors - Neurodegenerative Diseases
- Calcitriol (VDR) Agonists
- Cannabinoid Receptors - Analgesics
- Cannabinoid Receptors - Antidepressant
- Cannabinoid Receptors - Anxiolytic
- Cannabinoid Receptors - Sedatives
- capsaicin
- carbapenems
- Carcinogens and Mutagens
- Cardiovascular
- Carotenoids
- CCK Receptor Antagonists
- CCK Release Inhibitors
- CCK Release Stimulators
- Cell Membrane Modifiers
- cephalosporins
- chemicals for COVID-19 research
- CHIR99021
- cholesterol
- cisplatin
- Class I (Na+ Channel Blocker)
- Class II (Beta Blocker)
- Class III (K+ Channel Blocker)
- Class IV (Ca2+ Channel Blocker)
- Class V (Other)
- clostomicin
- Compounds targeting DNA synthesis and repair
- COMT - Neurodegenerative Diseases
- Contraceptives
- copanlisib
- coronavirus
- Corticosteroids and Modulators
- Corticotropin Releasing Factor
- cortisol
- Cortisol/one
- COVID-19 chemicals
- COVID-19 compounds
- COX - Analgesics
- COX-1 - Analgesics
- COX-2 - Analgesics
- Coxibs
- CPI-203
- cryptotanshinone
- CYP17A1 Inhibitors
- Cytidine/Cytosine
- D-amino Acid Oxidase - Analgesics
- D-amino Acid Oxidase - Antidepressant
- D-amino Acid Oxidase - Antipsychotic
- D-amino Acid Oxidase - Sedatives
- D1 Receptors - Analgesics
- D1 Receptors - Anesthetic
- D1 Receptors - Antidepressant
- D1 Receptors - Antipsychotic
- D1 Receptors - Anxiolytic
- D1 Receptors - Cognition Enhancing
- D1 Receptors - Neurodegenerative Diseases
- D1 Receptors - Sedatives
- D2 Receptor Antagonists
- D2 Receptors - Analgesics
- D2 Receptors - Anesthetic
- D2 Receptors - Antidepressant
- D2 Receptors - Antipsychotic
- D2 Receptors - Anxiolytic
- D2 Receptors - Cognition Enhancing
- D2 Receptors - Neurodegenerative Diseases
- D2 Receptors - Sedatives
- D3 Receptors - Analgesics
- D3 Receptors - Antidepressant
- D3 Receptors - Antipsychotic
- D3 Receptors - Anxiolytic
- D3 Receptors - Cognition Enhancing
- D3 Receptors - Neurodegenerative Diseases
- D3 Receptors - Sedatives
- D4 Receptors - Analgesics
- D4 Receptors - Antidepressant
- D4 Receptors - Antipsychotic
- D4 Receptors - Anxiolytic
- D4 Receptors - Cognition Enhancing
- D4 Receptors - Neurodegenerative Diseases
- D4 Receptors - Sedatives
- D5 Receptors - Antidepressant
- D5 Receptors - Antipsychotic
- D5 Receptors - Anxiolytic
- D5 Receptors - Cognition Enhancing
- D5 Receptors - Sedatives
- DA Receptor Signaling - Analgesics
- DA Receptor Signaling - Anesthetic
- DA Receptor Signaling - Antidepressant
- DA Receptor Signaling - Antipsychotic
- DA Receptor Signaling - Anxiolytic
- DA Receptor Signaling - Cognition Enhancing
- DA Receptor Signaling - Neurodegenerative Diseases
- DA Receptor Signaling - Sedatives
- daclatasvir
- dactylosporangium
- DAT - Antidepressant
- DAT - Neurodegenerative Diseases
- DAT - Sedatives
- DATS
- destruxin A
- destruxin B
- dexamethasone
- dexamethasone
- diallyl disulfide
- diallyl sulfide
- diallyl tetrasulfide
- diallyl trisulfide
- Dietary Supplements
- dihydroartemisinin
- Dihydrofolate Reductase
- Dihydrofolate Reductase Inhibitors
- diosmin
- dipropyl disulfide
- dipropyl sulfide
- Disinfectants
- Diuretics
- DNA and RNA Synthesis Inhibitors
- DNA Crosslinking and Alkylating Agents
- DNA Methyltransferase
- DNA Polymerase
- DNA Strand Break-Inducing Agents
- dopamine agonists
- Dopamine Receptor Inhibitors
- dopaminergic neurons
- dorsomorphin
- DOT1L Histone Methyltransferase
- DPP-4 Inhibitors
- dysoxylum
- ebastine
- Eicosanoid Inhibitors
- EIDD-2801
- EIDD2801
- eIF2B - Neurodegenerative Diseases
- elbasvir
- Endocrine Signaling and Immunology
- Endothelin Receptor Antagonists
- ensartinib
- eosin
- Epigenetic Modifiers
- Epinephrine/NE Agonists
- Ergosterol Inhibitors
- Essential vitamins and nutrients
- Estrogen Receptor Inhibitors
- Estrogens
- etoposide
- everolimus
- exclude-from-search
- EZH2 Histone Methyltransferase
- Factor Xa Inhibitors
- Fast Skeletal Muscle Troponin Complex - Neurodegenerative Diseases
- febuxostat
- Fertility Treatments
- Flavonoids
- Fluoroquinolones
- fumonisin
- Furans - Anti-parasitic
- Furans - Other nucleic acid inhibitors
- fusarenon
- GABA - Analgesics
- GABA - Anesthetic
- GABA - Antidepressant
- GABA - Antiepileptics and Anticonvulsants
- GABA - Antipsychotic
- GABA - Neurodegenerative Diseases
- GABA - Sedatives
- Gamma Secretase - Neurodegenerative Diseases
- Gastric Inhibitory Peptide
- Gastrin Agonists
- Gastrin-releasing Peptide
- Gastrointestinal Motility Modulators
- GDC-0032
- GDC-0941
- GDC-0973
- GDC-0980
- Ghrelin Agonists
- GHRH Agonists
- Ginkgolides and other Ginkgo-related Compounds
- ginsenoside
- Ginsenosides and Other Ginseng-related Compounds
- givinostat
- GLP-1 Agonists
- Glucagon Agonists
- Glucocorticoids
- Glucocorticoids - Other Therapies
- glucosinolate
- glycolysis
- glycopeptides
- glycylcyclines
- GlyR - Anesthetic
- GnRH Agonists
- gossypol
- GSK-3
- GSK-3 - Analgesics
- GSK-3 - Cognition Enhancing
- GSK-429286A
- guanosine
- Guanosine/Guanine
- gulf war illness
- Gut/Gastrointestinal Hormones
- GW-5074
- hesperidin
- Histamine Receptors - Analgesics
- Histamine Receptors - Antidepressant
- Histamine Receptors - Antipsychotic
- Histamine Receptors - Anxiolytic
- Histamine Receptors - Cognition Enhancing
- Histamine Receptors - Hypnotics
- Histamine Receptors - Neurodegenerative Diseases
- Histamine Receptors - Sedatives
- Histone Deacetylase
- HMG-CoA Reductase Inhibitors (Statins)
- Hormone Receptor Modulators
- Hs578T
- Hs578Ts(i)8
- HSP70
- HSP90
- huntington's
- hydrocortisone
- hydrocortisone
- Hypnotics
- hypoerphosphorylated tau
- Hypothalamic-Pituitary Hormones
- Imidazoles
- Imidazoline Receptors - Analgesics
- Imidazoline Receptors - Antipsychotic
- Imidazoline Receptors - Cognition Enhancing
- Imidazoline Receptors - Neurodegenerative Diseases
- Imidazoline Receptors - Sedatives
- Immunostimulatory
- Immunosuppressive
- Indoleamine 2,3-dioxygenase
- Inhibitors of other enzymes
- Insulin Secretagogues
- Insulin Sensitizers
- Integrase Inhibitors
- Ion Channels - Analgesics
- Ion Channels - Anesthetic
- Ion channels - Antidepressant
- Ion Channels - Antiepileptics and Anticonvulsants
- Ion Channels - Antipsychotic
- Ion Channels - Anxiolytic
- Ion Channels - Cognition Enhancing
- Ion Channels - Hypnotics
- Ion Channels - Neurodegenerative Diseases
- Ion Channels - Sedatives
- ionophores
- irbesartan
- isomer
- Isothiocyanate
- JAK-STAT
- K+ ATP Channel Blockers
- K+ Channels - Analgesics
- K+ Channels - Anesthetic
- K+ Channels - Antidepressant
- K+ Channels - Antiepileptics and Anticonvulsants
- K+ Channels - Antipsychotic
- K+ Channels - Anxiolytic
- K+ Channels - Cognition Enhancing
- K+ Channels - Hypnotics
- K+ Channels - Sedatives
- K+ Ion Channels - Neurodegenerative Diseases
- kashin-beck
- Kinesin Inhibitors
- Kynurenine 3-hydroxylase - Neurodegenerative Diseases
- lactulose
- Laxatives
- ledipasvir
- Leptin Agonists
- lestaurtinib
- Leukotriene Receptor Antagonists
- lincosamides
- Lipotropin Agonists
- Lipoxygenase - Analgesics
- Lisinopril
- losartan
- Lovastatin
- LRRK2 - Neurodegenerative Diseases
- LY-2606368
- LY2606368
- M2 Protein Inhibitors
- mAChR - Analgesics
- mAChR - Anesthetic
- mAChR - Antidepressant
- mAChR - Antipsychotic
- mAChR - Hypnotics
- mAChR - Neurodegenerative Diseases
- mAChR - Sedatives
- macrolides - 50S
- Macrolides - Anti-parasitic
- Madagascar periwinkle
- MAO - Analgesics
- MAO - Antidepressant
- MAO - Antiepileptics and Anticonvulsants
- MAO - Neurodegenerative Diseases
- MAO - Sedatives
- Marine Toxins
- masitinib
- Mast Cell Stabilizers
- MCH Agonists
- Meglitinides
- Melanocyte Stimulating Hormone
- Melatonin Receptors - Analgesics
- Melatonin Receptors - Antidepressant
- Melatonin Receptors - Anxiolytic
- Melatonin Receptors - Hypnotics
- Melatonin Receptors - Neurodegenerative Diseases
- Melatonin Receptors - Sedatives
- methylprednisolone
- mGlu - Sedatives
- mGluR - Antiepileptics and Anticonvulsants
- Microtubule Polymerization/Depolymerization Inhibitors
- Midostaurin
- Mineralocorticoids
- Monoamine Neurotransmitters
- monobactams
- Motilin Agonists
- MSH Agonists
- Mucolytics
- Muscarininc Acetylcholine Receptor Inhibitors
- Mycotoxins
- N-Arylanthranilic acid Derivatives (Fenamates)
- Na+ Channels - Analgesics
- Na+ Channels - Anesthetic
- Na+ Channels - Antidepressant
- Na+ Channels - Antiepileptics and Anticonvulsants
- Na+ Channels - Antipsychotic
- Na+ Channels - Anxiolytic
- Na+ Channels - Cognition Enhancing
- Na+ Channels - Sedatives
- Na+ Ion Channels - Neurodegenerative Diseases
- nAChR - Analgesics
- nAChR - Anesthetic
- nAChR - Antidepressant
- nAChR - Antiepileptics and Anticonvulsants
- nAChR - Neurodegenerative Diseases
- nAChR - Sedatives
- nanostructure lipid carrier
- Natural Products
- NCCT Inhibitors (Thiazide/Thiazide-like diuretics)
- neosolaniol
- NET - Analgesics
- NET - Antidepressant
- NET - Antipsychotic
- NET - Hypnotics
- NET - Neurodegenerative Diseases
- NET - Sedatives
- Neuraminidase Inhibitors
- Neurodegenerative Diseases
- Neuroscience
- Neurotoxins
- Neurotransmitters
- New Products
- News
- Nitrates
- Nitrogen Mustards
- Nitroimidazoles - Anti-parasitic
- Nitroimidazoles - Antibacterial
- Nitrosoureas
- Nitrovasodilators
- NK - Analgesics
- NK - Neurodegenerative Diseases
- NKCC1 Inhibitors (Loop Diuretics)
- NMDA - Analgesics
- NMDA - Anesthetic
- NMDA - Antidepressant
- NMDA - Antiepileptics and Anticonvulsants
- NMDA - Antipsychotic
- NMDA - Sedatives
- NMDA Receptors - Neurodegenerative Diseases
- NMS-E628
- non-tuberculous mycobacteria
- NSAID
- NSAIDs
- NSAIDs: COX-1 Inhibitors
- NSAIDs: COX-2 Inhibitors
- nu2058
- Nucleoside and Nucleotide Analogs
- Nucleoside/Nucleotide analogs
- odontoblast
- Okadiac Acid Sodium
- Opioid Peptide Agonists
- Opioid Receptor Agonists
- Opioid Receptor Antagonists
- Opioid Receptors - Analgesics
- Opioid Receptors - Anesthetic
- Opioid Receptors - Antidepressant
- Opioid Receptors - Antiepileptics and Anticonvulsants
- Opioid Receptors - Anxiolytic
- Opioid Receptors - Cognition Enhancing
- Opioid Receptors - Neurodegenerative Diseases
- Opioid Receptors - Sedatives
- Orexin Receptors - Sedatives
- organosulfur
- Organosulfurs
- Organosulfurs - Anti-parasitic
- osimertinib
- Other Analogs
- Other Compounds
- Other DA Signaling - Analgesics
- Other DA Signaling - Anesthetic
- Other DA Signaling - Antidepressant
- Other DA Signaling - Antipsychotic
- Other DA Signaling - Anxiolytic
- Other DA Signaling - Cognition Enhancing
- Other DA Signaling - Neurodegenerative Diseases
- Other DA Signaling - Sedatives
- Other Diuretics
- Other Hormones and Modulators
- Other Ion Channels - Analgesics
- Other Ion Channels - Anesthetic
- Other Ion Channels - Antidepressant
- Other Ion Channels - Antiepileptics and Anticonvulsants
- Other Ion Channels - Antipsychotic
- Other Ion Channels - Anxiolytic
- Other Ion Channels - Cognition Enhancing
- Other Ion Channels - Sedatives
- Other Lipid-lowering Compounds
- Other Neurotransmitters
- Other NSAID
- Other Nucleic Acid Inhibitors
- Other Products
- Other Targets
- Other Therapies
- Others
- Others - Antibacterial
- Others - Antidiabetic
- Others - Antithrombotic
- Others - Cell Membrane Modifiers
- Others - Ergosterol Inhibitors
- Others - Other nucleic acid inhibitors
- OTX-015
- outofstock
- Oxicams
- p110
- p110alpha
- Parathyroid Hormone Agonists
- parkinson's
- Parkinson's Disease
- penicillins
- Peptide Neurotransmitters
- Peptides
- Pesticides
- Pevonedistat
- PF-07321332
- Pharmaceutical Impurities and Derivatives
- Pharmaceutical Impurities and Derivatives
- Phytoestrogens
- phytosterol
- Pictrelisib
- Piperazines
- Platinum-based Agents
- polyenes
- polymixins
- polysulfide
- PPAR Agonists
- PPAR Agonists (Fibrates)
- PPAR-a Agonists
- PPAR-y Agonists
- prednisolone
- prednisone
- prednisone acetate
- prexasertib
- pristimerin
- Profens
- Progesterone
- Progestins
- Progestogens/Progestins
- Prolactin-releasing Peptide Agonists
- Prolyl Oligopeptidase - Neurodegenerative Diseases
- Propionic Acid Derivatives
- Prostaglandin D Synthase Inhibitors
- Prostaglandin Synthetase - Analgesics
- Protease Inhibitors
- proteasome
- Protein Arginine Methyltransferase
- Protein synthesis Inhibitors
- Proton Pump Inhibitors
- Purine derivatives
- Pyrazolidines
- quinghaosu
- Quinolones
- Ras
- remdesivir
- Renin Inhibitors
- Reverse Transcriptase Inhibitors
- Ribonucleotide Reductase
- RNA Polymerase
- ROS1
- rosiglitazone
- rosuvastatin
- salbutamol
- Salicylates
- Sapanisertib
- saquinavir
- SARS-CoV-2
- SARS-CoV2
- SB-203580
- SB-431542
- Secretin Agonists
- securinine
- Sedative
- Sedatives and Hypnotics
- seizure
- Self-Renewal
- selitrectinib
- ser910
- ser935
- Serine/Threonine Kinase Inhibitors
- SERM
- Serotonin (5-HT3) Receptor Inhibitors
- Serotonin Receptors - Analgesics
- Serotonin Receptors - Antidepressant
- Serotonin Receptors - Antipsychotic
- Serotonin Receptors - Anxiolytic
- Serotonin Receptors - Cognition Enhancing
- Serotonin Receptors - Hypnotics
- Serotonin Receptors - Neurodegenerative Diseases
- Serotonin Receptors - Sedatives
- SERT - Analgesics
- SERT - Antidepressant
- SERT - Antipsychotic
- SERT - Anxiolytic
- SERT - Cognition Enhancing
- SERT - Hypnotics
- SERT - Neurodegenerative Diseases
- SERT - Sedatives
- sesterterpenoid
- Sex steroids and Modulators
- Sigma Receptors - Antidepressant
- Sigma Receptors - Antiepileptics and Anticonvulsants
- Sigma Receptors - Antipsychotic
- Sigma Receptors - Anxiolytic
- Sigma Receptors - Cognition Enhancing
- Sigma Receptors - Neurodegenerative Diseases
- Sigma Receptors - Sedatives
- simeprevir
- simple
- simurosertib
- sirolimus
- SIRT - Neurodegenerative Diseases
- SMAC
- Snake Venoms
- SNS-032
- sofosbuvir
- sofosbuvir
- Somatostatin Agonists
- sorafenib
- Soy Isoflavones
- src
- SRp75
- stain
- STAT
- statin
- staurosporine
- Stem Cell Modulators
- Steroids Hormones and Modulators
- STING
- sting ligand
- streptogramins
- su5402
- su9516
- substantia nigra
- sulbactam
- Sulfonamides
- Sulfonylureas
- Surfactants
- survivin
- Sutezolid
- swainsonine
- synephrine
- TAAR - Sedatives
- taselisib
- tau tangles
- Taxols
- Telomerase
- tetracyclines - 30S
- Tetracyclines - Anti-parasitic
- Tetrahydropyrimidines
- Therapies for Respiratory Diseases and Allergy Management
- Thiazoles
- Thioredoxin Reductase
- Thrombin Inhibitors
- Thromboxane Receptor Antagonists
- Thymidylate Synthase
- Thymopoietin/Thymopentin Agonists
- Thymosin Agonists
- Thymulin Agonists
- Thyroid Hormone Agonists
- Thyroid Hormones and Modulators
- Tocolytics
- Topoisomerase
- Topoisomerase Inhibitors
- tosufloxacin
- tranilast
- Transcription Factor Modifiers
- trehalose
- TRH Agonists
- Triazoles
- trichothecenes
- Triple-negative breast cancer
- Trk Receptors - Cognition Enhancing
- Trk Receptors - Neurodegenerative Diseases
- TRP Channels - Analgesics
- TRP Channels - Anesthetic
- TRP Channels - Antidepressant
- TRP Channels - Antiepileptics and Anticonvulsants
- TRP Channels - Antipsychotic
- TRP Channels - Anxiolytic
- TRP Channels - Cognition Enhancing
- TRP Channels - Neurodegenerative Diseases
- TRP Channels - Sedatives
- TTK/Mps
- tuberculosis
- tuberculosis
- Tubulin Inhibitors
- Tyrosine Kinase Inhibitors
- UNC0064-12
- uprosertib
- USP40 Taxol Impurities - Cell Fermentation
- USP40 Taxol Impurities - Isolated
- USP40 Taxol Impurities - Semisynthetic
- V600E
- Vasodilatory
- Vasopressin Agonists
- velpatasvir
- vinblastine
- Vinca Alkaloids
- vincristine
- vinleurosine
- VIP Agonists
- Viral Fusion and Entry Inhibitors
- Vitamin K Antagonists
- voglibose
- wc_update_product_lookup_tables
- Website Updates
- woocommerce-db-updates
- α1-adrenergic Receptor Antagonists - Antihypertensive
- α1-adrenergic Receptor Antagonists - Vasodilatory
- α2-adrenergic Receptor Agonists
- β-Glucan Synthase Inhibitors (echinocandins)
- β-lactamase inhibitors
- β-Lactams
Product Matches
Product ID
Name
Description
Purity
- AS104Camptothecins Standards Kit
7 camptothecins
- AS103Skullcap Standards Kit
Baicalin, Wogonin
- AS102Aristolochic Acids Standards Kit
A, B, C, & 7-Hydroxy-A
- AS101Chamomile Flavonoid Standards Kit
Luteolin, Apigenin
- G6803Granuliberin R
Antimicrobial peptide found in amphibians.
≥95% - D183745Destruxin B
Cyclic depsipeptide is a secondary metabolite isolated from the fungus Metarh...
≥96% - D183744Destruxin A
Cyclic depsipeptide is a secondary metabolite isolated from the fungus Metarh...
≥98% - M578522Monascin
Fungal pigment found in red yeast rice
≥98% - E6783R-Equol
Isoflavone, phytoestrogen found in soy
≥98% - F3208Fibrinopeptide B, human
Antimicrobial peptide, generated during fibrin formation.
≥95% - L8011D-Luciferin Sodium
Heterocyclic light-emitting compound, natural ligand for luciferase, detects ...
≥99% - L8010D-Luciferin Potassium
Heterocyclic light-emitting compound, natural ligand for luciferase, detects ...
≥98% - L8009D-Luciferin 1-(4,5-dimethoxy-2-nitrophenyl) Ethyl Ester
Cell-membrane permeable heterocyclic light-emitting compound, natural ligand ...
≥95% - C5647Colistin Sulfate
Polymixin, antimicrobial peptide, induces formation of pores in membrane; NAD...
Biological Potency: ≥19366 IU/mg - P0268Parasin I
Histone H2-derived antimicrobial peptide found in Parasilurus.
≥95% - L8008D-Luciferin, firefly, Free Acid
Heterocyclic light-emitting compound, natural ligand for luciferase, detects ...
≥98% - AS115Celery Standards Kit
6 celery phytochemicals
- C2801Chaetoglobosin A
Cytotoxic and antifungal activities.
≥99% - AS114Citrus Flavonoids Standards Kit
6 citrus flavonoids
- T564098Tocored
Tocopherol analog